Evidence map›Paper›PMID 31414402›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2019

ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder.

Ryan Marino, Jeanmarie Perrone, Lewis S Nelson, Timothy J Wiegand, Evan S Schwarz, Paul M Wax, Andrew I Stolbach

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Pharmacists and opioid use disorder care during COVID-19: Call for action.Journal of the American College of Clinical Pharmacy : JACCP · 2022
    Article
  5. Article
  6. Descriptive Analysis of Inpatient and Outpatient Cohorts Seeking Treatment After Prescription Opioid Misuse and Medical Toxicology Evaluation.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2021
    Article
  7. Implementation of a Medication for Addiction Treatment (MAT) and Linkage Program by Leveraging Community Partnerships and Medical Toxicology Expertise.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ryan MarinoCase Western Reserve University School of Medicine, Cleveland, OH, USA. positionstatements@acmt.net.
Jeanmarie PerroneUniversity of Pennsylvania, Philadelphia, PA, USA.
Lewis S NelsonRutgers New Jersey Medical School, Newark, NJ, USA.
Timothy J WiegandUniversity of Rochester Medical Center, Rochester, NY, USA.
Evan S SchwarzDivision of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Paul M WaxUniversity of Texas Southwestern, Dallas, TX, USA.
Andrew I StolbachJohns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overBuprenorphineConsent FormsDrug PrescriptionsFemaleHumansMaleMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersPractice Guidelines as TopicSocieties, MedicalUnited StatesBuprenorphineBuprenorphineOpioid agonist therapyOpioid use disorderWaiverX-waiver

Identifiers

PMID31414402
PMCPMC6825058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.